Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Link opens in a new tab
Search content at Maastricht University
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Endobronchial valves for severe emphysema
Jorine E. Hartman
*
, Lowie E. G. W. Vanfleteren
, Eva M. van Rikxoort
, Karin Klooster
, Dirk-Jan Slebost
*
Corresponding author for this work
Pulmonologie
NUTRIM - Healthy Ageing
Research output
:
Contribution to journal
›
(Systematic) Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endobronchial valves for severe emphysema'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Severe Emphysema
100%
Endobronchial Valves
100%
Endobronchial Valve Treatment
100%
Randomized Controlled Trial
50%
Treatment Options
50%
Hospital Costs
50%
Adverse Events
50%
Long-term Efficacy
50%
Advanced Cancer Patients
50%
Patient Selection
50%
Pulmonary Rehabilitation
50%
Reduction Method
50%
Risk Prediction
50%
U.S. Food
50%
Clinical Practice Guidelines
50%
Routine Care
50%
National Registry
50%
Impact Event
50%
Pneumothorax
50%
One-way Valve
50%
Bronchoscopic Lung Volume Reduction
50%
Lung Volume Reduction Surgery
50%
Valve Treatment
50%
Number of Patients
50%
Nursing and Health Professions
Pulmonary Rehabilitation
100%
Adverse Event
100%
Practice Guideline
100%
Emphysema
100%
Patient Selection
100%
Hospitalization Cost
100%
Pneumothorax
100%
Food and Drug Administration
100%
Lung Volume
100%
Lung Resection
100%
INIS
valves
100%
emphysema
100%
positioning
40%
lungs
40%
patients
40%
reduction
40%
volume
40%
increasing
40%
inclusions
40%
surgery
20%
risks
20%
cost
20%
guidelines
20%
implementation
20%
food and drug administration
20%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Adverse Event
100%
Emphysema
100%
Pneumothorax
100%
Medicine and Dentistry
Emphysema
100%
Endobronchial Valve
100%
Health Care Cost
25%
Pulmonary Rehabilitation
25%
Randomized Controlled Trial
25%
Adverse Event
25%
Patient Selection
25%
Lung Volume
25%
Pneumothorax
25%
Pneumonectomy
25%